ZIM Laboratories Limited (ZIMLAB.NS)
INR 86.66
(0.79%)
INR 86.66
(0.79%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 812.62 Million INR | 51.31% |
| 2022 | 537.06 Million INR | -28.66% |
| 2021 | 752.84 Million INR | 38.52% |
| 2020 | 543.47 Million INR | -3.62% |
| 2019 | 563.89 Million INR | 2.43% |
| 2018 | 550.52 Million INR | 6.77% |
| 2017 | 515.6 Million INR | 45.38% |
| 2016 | 354.65 Million INR | -5.97% |
| 2015 | 377.18 Million INR | -18.18% |
| 2014 | 460.99 Million INR | 48.04% |
| 2013 | 311.39 Million INR | 31.83% |
| 2012 | 236.21 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 812.62 Million INR | 51.31% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 812.62 Million INR | 0.0% |
| 2023 Q2 | 660.75 Million INR | 0.0% |
| 2022 FY | 537.06 Million INR | -28.66% |
| 2022 Q4 | 537.06 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 723.26 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 752.84 Million INR | 38.52% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 612.35 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 752.84 Million INR | 0.0% |
| 2020 Q2 | 484.98 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 543.47 Million INR | 0.0% |
| 2020 FY | 543.47 Million INR | -3.62% |
| 2019 FY | 563.89 Million INR | 2.43% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 636.07 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 563.89 Million INR | 0.0% |
| 2018 Q4 | 550.52 Million INR | 0.0% |
| 2018 FY | 550.52 Million INR | 6.77% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 605.86 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q4 | 515.6 Million INR | 0.0% |
| 2017 FY | 515.6 Million INR | 45.38% |
| 2016 FY | 354.65 Million INR | -5.97% |
| 2015 FY | 377.18 Million INR | -18.18% |
| 2014 FY | 460.99 Million INR | 48.04% |
| 2013 FY | 311.39 Million INR | 31.83% |
| 2012 FY | 236.21 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.056% |
| Hester Biosciences Limited | 755.81 Million INR | -7.518% |
| Aarti Drugs Limited | 4.85 Billion INR | 83.275% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 87.359% |
| Albert David Limited | 436.12 Million INR | -86.331% |
| Alembic Limited | 113.4 Million INR | -616.604% |
| Alkem Laboratories Limited | 26.61 Billion INR | 96.946% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -174.15% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 43.582% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -3087.155% |
| Brooks Laboratories Limited | 96.1 Million INR | -745.537% |
| Eris Lifesciences Limited | 1.89 Billion INR | 57.011% |
| FDC Limited | 3.88 Billion INR | 79.104% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 87.809% |
| Gufic Biosciences Limited | 2 Billion INR | 59.466% |
| Hikal Limited | 3.03 Billion INR | 73.244% |
| Ind-Swift Limited | 640.91 Million INR | -26.792% |
| Innova Captab Limited | 1.44 Billion INR | 43.574% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 80.872% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -441.861% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 93.699% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -5.306% |
| Lupin Limited | 49.53 Billion INR | 98.36% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 34.274% |
| Medico Remedies Limited | 163.37 Million INR | -397.41% |
| Morepen Laboratories Limited | 2.48 Billion INR | 67.311% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 88.541% |
| Orchid Pharma Limited | 2.64 Billion INR | 69.245% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 25.522% |
| RPG Life Sciences Limited | 1.01 Billion INR | 19.542% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -1937.686% |
| Sigachi Industries Limited | 707.2 Million INR | -14.907% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 77.408% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 64.851% |
| Themis Medicare Limited | 705.74 Million INR | -15.145% |
| Unichem Laboratories Limited | 7.04 Billion INR | 88.468% |
| Vaishali Pharma Limited | 3.79 Million INR | -21301.87% |
| Wanbury Limited | 360.23 Million INR | -125.585% |
| Windlas Biotech Limited | 621.89 Million INR | -30.671% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -677.063% |
| Ipca Laboratories Limited | 24.71 Billion INR | 96.712% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.177% |
| Venus Remedies Limited | 1.21 Billion INR | 33.221% |
| Sakar Healthcare Limited | 277.32 Million INR | -193.026% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.171% |
| Divi's Laboratories Limited | 31.84 Billion INR | 97.448% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 64.34% |
| Mankind Pharma Limited | 15.53 Billion INR | 94.769% |
| Sequent Scientific Limited | 3.46 Billion INR | 76.529% |
| Laurus Labs Limited | 18.45 Billion INR | 95.596% |
| Neuland Laboratories Limited | 3.5 Billion INR | 76.81% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 83.829% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 96.766% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 97.639% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -181.141% |
| Wockhardt Limited | 6.4 Billion INR | 87.303% |
| Bal Pharma Limited | 878.11 Million INR | 7.457% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.721% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 31.393% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -1845.485% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 77.616% |
| Shilpa Medicare Limited | 3.44 Billion INR | 76.441% |
| Valiant Laboratories Limited | 100.15 Million INR | -711.379% |
| Ajanta Pharma Limited | 8.28 Billion INR | 90.19% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -134.351% |
| Granules India Limited | 13 Billion INR | 93.752% |
| Medicamen Biotech Limited | 593.75 Million INR | -36.863% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -285.47% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.434% |
| NATCO Pharma Limited | 7 Billion INR | 88.399% |
| Suven Life Sciences Limited | 7.08 Million INR | -11369.711% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -729.518% |
| Strides Pharma Science Limited | 11.26 Billion INR | 92.785% |
| Indoco Remedies Limited | 3.53 Billion INR | 76.983% |
| Alpa Laboratories Limited | 136.65 Million INR | -494.666% |
| Lasa Supergenerics Limited | 190.43 Million INR | -326.725% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -5393.706% |